Found: 6
Select item for more details and to access through your institution.
Long-term prophylaxis with lanadelumab for HAE: authorization for temporary use in France.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2022, v. 18, n. 1, p. 1, doi. 10.1186/s13223-022-00664-4
- By:
- Publication type:
- Article
A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome.
- Published in:
- Sleep & Breathing, 2011, v. 15, n. 1, p. 13, doi. 10.1007/s11325-009-0320-0
- By:
- Publication type:
- Article
A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome.
- Published in:
- Sleep & Breathing, 2011, v. 15, n. 1, p. 13, doi. 10.1007/s11325-009-0320-0
- By:
- Publication type:
- Article
HAE patient self-sampling for biomarker establishment.
- Published in:
- 2021
- By:
- Publication type:
- Journal Article
Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study.
- Published in:
- Clinical & Experimental Allergy, 2021, v. 51, n. 10, p. 1391, doi. 10.1111/cea.13974
- By:
- Publication type:
- Article
Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 979, doi. 10.1111/all.15011
- By:
- Publication type:
- Article